tHIS 2015
SHANGHAI - Wednesday, June 25th 2014 [ME NewsWire]
(BUSINESS
WIRE)-- Reed Sinopharm Exhibitions, the leading healthcare event
organizer in China, announced Wednesday the launch of The Health
Industry Summit (tHIS) in Shanghai. This new event, to be held 15-18 May
2015 at National Exhibition and Conference Center (Shanghai), the
world’s largest single block exhibition complex, will combine a Summit
program of over 100 conferences with a gigantic 260,000 sqm exhibition
area through co-locating three of the leading health industry
exhibitions, namely CMEF, PHARMCHINA, API CHINA, effectively forming the
world’s largest integrated health industry event.
It is not
surprising that Reed Sinopharm, a joint venture between China’s
state-owned Sinopharm Group and the world’s leading event organizer Reed
Exhibitions, decided to launch such a grand international event. With
China predicting its health industry to grow into an RMB 8 trillion (USD
1.2 trillion) industry by 2020, and a strengthening of health sector
demand, the move is clearly intended to secure more international trade
and influence for China’s already sizable sector.
Along with the
exhibition which completes the value chain for pharmaceutical and
medical industries, an extensive conference program is designed to share
the latest thinking on policies and investment, R&D, manufacturing
and distribution, professional education and hospital applications. It
is estimated that more than 6000 exhibitors and a staggering 150,000
professional visitors and leading academics from 140 countries and
regions will land in Shanghai next May to join this unique event,
bringing in significant business service and tourism revenue
opportunities to the city.
Apart from scale, tHIS has also
positioned itself as the platform to explore synergies emerging from the
interactions between and within the Pharmaceutical and Medical sectors,
which share a significant base of distributors and end users, as more
and more companies begin to operate in a cross-sector capacity.
As
China’s healthcare sector only accounts for around 5% of China’s GDP,
there remains abundant potential for further investments and growth
especially when it is being fueled by favorable demographic trends and
continuing urbanization in decades to come. However, many industry
players believe that while further growth in the sector is attainable,
there will likely be fierce industry restructuring. The competitiveness
of the local enterprises and the environment which foster innovation
will need improving before China can realize the future it has
envisioned.
Contacts
Reed Sinopharm Exhibitions
James Wang, +86-10-59339302
james.wang@reedexpo.com.cn
Permalink: http://me-newswire.net/news/11441/en
No comments:
Post a Comment